SEC Filing Summary for Elanco Animal Health Inc. - Officer Transaction

2026-04-07SEC Filing 4 (0001724169-26-000017)

This filing details a transaction by Robert M. VanHimbergen, EVP and CFO of Elanco Animal Health Inc. On April 3, 2026, Mr. VanHimbergen acquired 8.6337 Deferred Stock Units (DSUs) with a price of $22.82 per unit. These DSUs represent the right to receive one share of the company's common stock or its cash equivalent. Following this transaction, Mr. VanHimbergen holds 57.4266 DSUs. The DSUs are set to settle in cash or shares of common stock after termination of employment or in a specified future year, as per the Executive Deferral and Stock Match Plan. The filing is Form 4, indicating a change in beneficial ownership.